Rifampin is a potent inducer of the cytochrome P450 enzyme system, particularly CYP3A4. This induction leads to increased metabolism of co-administered drugs, potentially reducing their efficacy. It can affect the metabolism of numerous drugs, including oral contraceptives, anticoagulants, and antiretrovirals, necessitating careful management of drug interactions to avoid therapeutic failures or toxicity.
